4//SEC Filing
McHale Duncan 4
Accession 0001694665-20-000010
CIK 0001694665other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:26 PM ET
Size
5.4 KB
Accession
0001694665-20-000010
Insider Transaction Report
Form 4
McHale Duncan
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-01-28+117,000→ 117,000 totalExercise: $7.06Exp: 2030-01-27→ Common Stock (117,000 underlying)
Footnotes (1)
- [F1]These options will vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of January 9, 2020, subject to continued employment on such dates.
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001738896
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:26 PM ET
- Size
- 5.4 KB